Navigation Links
Germany Hosts World Leading Medical Industry Fair
Date:11/13/2007

DUSSELDORF, Germany, November 13 /PRNewswire/ -- MEDICA is the world's leading medical industry trade fair. Over 2,000 international exhibitors will gather here, from November 14th-17th, to present new advances and technologies for in-patient and out-patient care.

Germany's strengths in medical devices go beyond possessing Europe's largest market and a legacy of great scientific discovery. Rather, the German government is working to enhance research and development (R&D) and therefore ensure the industry's staying power. As part of Germany's "high-tech strategy," the country is making EUR800 million available for research and development in health research and medical technologies through the end of 2009.

In 2006, EUR21 billion were spent on medical devices in Germany making the country Europe's largest medical devices market, and it is growing. In the same year, domestic sales in the German medical devices industry brought in EUR15.9 billion, an increase of 8.1% over the previous year. Export sales also increased hitting a total of EUR10.2 billion in 2006-an improvement of 11.1% over the previous year and moving Germany's rank to second in medical devices exports.

The German medical device industry has major players such as Siemens Medical Solutions and Fresenius AG that are among the world's top 10 in the industry. Besides these leaders there are many small and mid-sized companies that are market leaders in their respective sub-segments. Market conditions such as Germany's track record in precision production and its excellent R&D landscape make it an attractive place for foreign medical devices companies. For example, leading international companies, such as Johnson & Johnson and GE Healthcare Technologies Inc. are major investors in Germany.

The country's demographic development combined with its high standard of health care also leads it to demand world-class medical devices. Nearly one-fifth of the German population is over age 6
'/>"/>

SOURCE Invest in Germany
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spectral partner launches EAA(TM) Rapid Sepsis Diagnostic in Germany
2. Arpida Presents Data on Iclaprim at Scientific Congress in Germany
3. Luminex Corporation Hosts the Fifth Annual Planet xMAP Europe 2007 Symposium
4. Pharsight Hosts Fourth Annual PKS User Group Meeting
5. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
6. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
7. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
8. Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in Worlds Largest Stent Registry
9. CeloNova BioSciences Announces Worlds First Line of Fully Color-Coded Embolic Particles at CIRSE: Embozene(TM) Color-Advanced Microspheres
10. Stereotaxis Niobe System Used to Perform More Than 10,000 Procedures Worldwide
11. NexGenix Pharmaceuticals Enters into Exclusive World-wide License to Develop Novel Hsp90 Inhibitors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... Toronto, Canada (PRWEB) January 14, 2014 ... and its motives and methods in product development and ... of the industry. This mistrust, fueled by concerns about ... further fed by reports of spectacular fines to the ...
(Date:1/14/2014)... Ontario , Jan. 14, 2014   Kinaxis ®, provider ... SCM ) and sales and operations planning ( S&OP ) ... Biomanufacturing Summit , which will be held at the ... the conference, join Kinaxis customer Elisabeth Kaszas , Director ...
(Date:1/14/2014)... 14, 2014 During the 1600’s through the ... “The Doctor’s Plague.” In this time period, doctors did not ... at times, to the death of vulnerable patients. In the ... that they may be unwittingly transmitting herpes viruses to their ...
(Date:1/14/2014)... Holloway America today announced an addition ... reports (MTRs) for all pressure vessels and tank parts ... particularly important for equipment that must meet ASME, CE, ... search functionality that allows authorized users to quickly locate ...
Breaking Biology Technology:The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 2Study: Fatigued Medical Interns Infect Their Patients with Herpes Viruses; The CBCD Sees a Parallel with “The Doctor’s Plague” 3Pressure Vessel Design and Fabrication Company Builds Database for Material Test Reports 2Pressure Vessel Design and Fabrication Company Builds Database for Material Test Reports 3
... Cephalon, Inc. (NASDAQ: CEPH ) today ... Statement with the Securities and Exchange Commission (SEC) urging ... remove Cephalon,s entire Board of Directors and replace them ... of the Statement to shareholders of record together with ...
... NEW YORK, April 21, 2011 Collins Stewart LLC ... healthcare investment banking alliance with Beal Advisors and Liberty ... target, originate and execute public and private equity transactions ... Tree Advisors are US-based boutique healthcare advisory firms. Georgia ...
... 21, 2011 The Stanford University School of ... of a Phase 1/2a clinical trial testing the ... therapy product, SB623, on patients suffering from stable ... regarding this clinical trial, please refer to the ...
Cached Biology Technology:Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 2Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 3Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 4Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 5Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 6Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 7Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 8Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 9Cephalon Files Definitive Consent Revocation Statement, Commences Mailing to Shareholders 10Collins Stewart Announces Formation of Healthcare Investment Banking Alliance 2Collins Stewart Announces Formation of Healthcare Investment Banking Alliance 3Stanford and SanBio Announce a Clinical Trial of Cell Therapy for Stroke Disability 2
(Date:4/20/2014)... crop residue to make ethanol and other biofuels reduces ... gasoline, according to a study published today in the ... by a University of Nebraska-Lincoln team of researchers cast ... meet federal mandates to ramp up ethanol production and ... stalks, leaves and cobs in cornfields after harvest -- ...
(Date:4/18/2014)... adds a twist to the story of how barnyard chickens ... 21 in the journal Proceedings of the National Academy ... chickens that lived 200-2300 years ago in Europe, researchers report ... have looked far different from the chickens we know today. ... associate with modern domestic chickens -- such as their yellowish ...
(Date:4/17/2014)... trials to treat tuberculosis could be the basis for ... bacteria, fungal infections and parasites, yet evade resistance, according ... collaborators. , Led by U. of I. chemistry professor ... drug SQ109 attacks the tuberculosis bacterium, how the drug ... to malaria and how targeting multiple pathways reduces ...
Breaking Biology News(10 mins):Study casts doubt on climate benefit of biofuels from corn residue 2Study casts doubt on climate benefit of biofuels from corn residue 3Ancient DNA offers clues to how barnyard chickens came to be 2Multitarget TB drug could treat other diseases, evade resistance 2
... origins of holiday giving and finds that our early ... arguably the foundational basis of cooperation in humans," writes ... feature of reciprocity is the contingent relationship between acts ... important because it sets the rules for who qualifies ...
... the United States could be grown inexpensively and safely ... of Central Florida molecular biologist has found. , Mice ... Daniell's laboratory through the genetic engineering of tobacco plants ... Institutes of Health researchers. The results of the NIH-funded ...
... -- a critical protein that mediates the body's defense against ... soon have greater therapeutic value as the result of a ... in St. Louis. , "Essentially, we found a way ... Michael J. Holtzman, M.D., the Selma and Herman Seldin Professor ...
Cached Biology News:Effective, safe anthrax vaccine can be grown in tobacco plants 2Effective, safe anthrax vaccine can be grown in tobacco plants 3Greasing interferon's gears may pave way to greater therapeutic benefits, fewer side effects 2
CQCS kit for first KR 4i , (first unit)....
... 384, compatible with hood ... handling system for 384-well ... accurately prepares large quantities ... The Wellpro also performs ...
...
...
Biology Products: